Column Group IV GP, LP, 10% Owner, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 1,016,638 shares at $13.50 ($13.7M) on 2022-06-09, disclosed to the SEC on 2022-06-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 32,477 | $438K | 3.2% |
| 2 | $13.50 | 32,477 | $438K | 3.2% |
| 3 | $13.50 | 951,684 | $12.8M | 93.6% |
| Total | $13.50 avg | 1,016,638 | $13.7M | 100% |
| Filing → |
| NGM | BUY | 2022-05-31 | $572K | — | Filing → |